Episode 8

Jack O'Meara, Aerska

Published on: 20th November, 2025

This isn't Jack O'Meara's first rodeo.

As CEO of Ochre Bio, he saw the company bring in millions to develop pioneering RNA therapies for liver disease. With his new venture Aerska, he's looking at bringing the transformative potential of targeted RNA therapy to the realm of neurological disease.

In this episode of A Call to Lead, David Kirk speaks with Jack O’Meara, CEO and co-founder of Aerska, about his personal story behind tackling neurodegenerative disease and the realities of leading biotech companies in Europe.

Jack shares candid lessons on decision-making, context-driven leadership, and building transatlantic networks to scale innovation.

All Episodes Previous Episode

Listen for free

Show artwork for A Call to Lead @LifeScience ORG

About the Podcast

A Call to Lead @LifeScience ORG
Sharing the leadership journeys of life science entrepreneurs shaping the future of healthcare.
A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare.

Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly.

New episodes are released every Thursday.